About human erythropo ietin
Erythropoiesis-stimulating agent
Used for
- Treats anaemia caused by chronic kidney disease.
- Treats anaemia in some adults receiving chemotherapy.
Usual adult dose
Dose is individualized by blood tests and treatment purpose; commonly starts at 20 IU/kg three times weekly for kidney-related anaemia.
Usual dose in children
For kidney-related anaemia, commonly 20 IU/kg three times weekly; specialist adjusts according to blood tests.
Common side effects
- High blood pressure
- Headache
- Blood clots
- Injection-site reactions
Important warnings
- May increase risk of heart attack, stroke, blood clots, or death, especially with high haemoglobin targets.
- Blood pressure and blood counts need monitoring.
- Not for immediate correction of severe anaemia.
- Use caution with seizure disorders or a history of blood clots.
Pregnancy
Use only when clearly needed; pregnancy data are limited. Prescriber should weigh benefits and risks.
Breastfeeding
Unknown whether it passes into breast milk; use requires clinical assessment.
Interactions
- Iron supplements may be needed to support treatment.
- Medicines that lower blood pressure may require adjustment if blood pressure rises.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.